CONQUER

The purpose of this study is to enroll a number of patients with early scleroderma, and to collect data on clinical outcomes, radiological tests, laboratory tests and to obtain biological specimens for testing.

NO. You do not have to take a medication for the study.

Systemic sclerosis (SSc) can affect patients in several ways, which include activities of daily living, quality of life, and increased healthcare costs. We hope to explore medical care and the impact of SSc on patients' daily lives through various questionnaires that will be collected during study participation. By looking at all of the areas mentioned, we hope to find out information about SSc that will help us treat future patients, develop new treatments, and work towards a cure.

Patients must have a diagnosis of systemic sclerosis (scleroderma) of less than 5 years.

Currently there is no set end date to the study.

After enrolling into the study, you will fill out a set of questionnaires at each study visit which is once every 6 months. Blood will be collected at every visit during the first year and then once a year after the 12-month point.

Thank you for your interest! If you wish to learn more and sign up for the study, please contact:

LAUREN BAKER
rheumatologyresearch@uphs.upenn.edu
215-614-4417